Tech Company Financing Transactions

Quartet Medicine Funding Round

Quartet Medicine closed a $17 million Series A venture capital round on 10/27/2014. Investors included Atlas Venture, Novartis Venture Fund and Partners Innovation Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.quartetmedicine.com

Email Address

[email protected]

Overview

Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gerhard Koenig

        

Browse more venture capital transactions:

Prev: 10/27/2014: Sandstone Diagnostics venture capital transaction
Next: 10/27/2014: Enjoy venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary